PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition
Pau Castel(Memorial Sloan Kettering Cancer Center), Maurizio Scaltriti(Memorial Sloan Kettering Cancer Center)
Cited by 228
Related Papers
Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer
|JNCI Journal of the National Cancer Institute|2007|876
Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer
|Molecular Cancer Therapeutics|2011|52
Cross-species analysis of LZTR1 loss-of-function mutants demonstrates dependency to RIT1 orthologs
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1